Abstract:N:6-methyladenosine (m6A), the most abundant internal modification on mRNAs in eukaryotes, play roles in adipogenesis. However, the underlying mechanism remains largely unclear. Here, we show that m6A plays a critical role in regulating macroautophagy/autophagy and adipogenesis through targeting Atg5 and Atg7. Mechanistically, knockdown of FTO, a well-known m6A demethylase, decreased the expression of ATG5 and ATG7, leading to attenuation of autophagosome formation, thereby inhibiting autophagy and adipogenesis. We proved that FTO directly targeted Atg5 and Atg7 transcripts and mediated their expression in an m6A-dependent manner. Further study identified that Atg5 and Atg7 were the targets of YTHDF2 (YTH N6-methyladenosine RNA binding protein 2). Upon FTO silencing, Atg5 and Atg7 transcripts with higher m6A levels were captured by YTHDF2, which resulted in mRNA degradation and reduction of protein expression, thus alleviating autophagy and adipogenesis. Furthermore, we generated an adipose-selective fto knockout mouse and find that FTO deficiency decreased white fat mass and impairs ATG5- and ATG7-dependent autophagy in vivo. Together, these findings unveil the functional importance of the m6A methylation machinery in autophagy and adipogenesis regulation, which expands our understanding of such interplay that is essential for development of therapeutic strategies in the prevention and treatment of obesity.ABBREVIATIONS:3-MA: 3-methyladenine; ACTB: actin, beta; ATG: autophagy-related; Baf A1: bafilomycin A1; CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha; CEBPB: CCAAT/enhancer binding protein (C/EBP), beta; FABP4: fatty acid binding protein 4, adipocyte; FTO: fat mass and obesity associated; HFD: high-fat diet; LC-MS/MS: liquid chromatography-tandem mass spectrometry; MAP1LC3B/LC3: microtubule-associated protein 1 light chain 3 beta; m6A: N6-methyladenosine; MEFs: mouse embryo fibroblasts; MeRIP-qPCR: methylated RNA immunoprecipitation-qPCR; PPARG: peroxisome proliferator activated receptor gamma; RIP: RNA-immunoprecipitation; SAT: subcutaneous adipose tissue; siRNA: small interfering RNA; SQSTM1/p62: sequestosome 1; TEM: transmission electron microscopy; ULK1: unc-51 like kinase 1; VAT: visceral adipose tissue; WAT: white adipose tissue; YTHDF: YTH N6-methyladenosine RNA binding protein.

FTO Promoted Adipocyte Differentiation by Regulating ADRB1 Gene Through M 6 A Modification in Hycole Rabbits

FTO regulates adipogenesis by controlling cell cycle progression via mA-YTHDF2 dependent mechanism.

FTO Regulated Intramuscular Fat by Targeting APMAP Gene via an m6A-YTHDF2-dependent Manner in Rex Rabbits

m 6 A methylation modulates adipogenesis through JAK2-STAT3-C/EBPβ signaling.

M6a Demethylase FTO Regulate CTNNB1 to Promote Adipogenesis of Chicken Preadipocyte

Trna-Derived Small Non-Coding RNAs As Novel Epigenetic Molecules Regulating Adipogenesis

FTO Promotes Adipogenesis Through Inhibition of the Wnt/β-catenin Signaling Pathway in Porcine Intramuscular Preadipocytes.

Loss of m 6 A on FAM134B promotes adipogenesis in porcine adipocytes through m 6 A-YTHDF2-dependent way.

M6a Mrna Methylation Controls Autophagy and Adipogenesis by Targeting Atg5 and Atg7

Inhibition of Fat Cell Differentiation in 3T3-L1 Pre-Adipocytes by All-Trans Retinoic Acid: Integrative Analysis of Transcriptomic and Phenotypic Data.

mRNA m6A methylation downregulates adipogenesis in porcine adipocytes

Fat mass and obesity‐associated protein regulates lipogenesis via m 6 A modification in fatty acid synthase mRNA

FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis

FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner

mRNA m⁶A methylation downregulates adipogenesis in porcine adipocytes.

The Fto Gene Regulates the Proliferation and Differentiation of Pre-Adipocytes in Vitro

Author Correction: NADP Modulates RNA M6a Methylation and Adipogenesis Via Enhancing FTO Activity

Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs

FTO regulates myoblast proliferation by controlling CCND1 expression in an m<SUP>6</SUP>A-YTHDF2-dependent manner

FTO Reduces Mitochondria and Promotes Hepatic Fat Accumulation Through RNA Demethylation

Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m<SUP>6</SUP>A methylation and increasing the stability of SREBF1 and ChREBP mRNAs